ARCHIVED 1. List of Drugs for Exceptional Importation and Sale [2022-01-28]
Drugs included on this list are called "designated drugs" and are eligible for the exceptional importation and sale provisions provided for in Interim Order No. 2. Health Canada maintains and updates the list as required. It’s the same list that was incorporated by reference in the previous IO for the exceptional importation and sale of drugs.
Supersedes: 2021-08-27
Date issued: 2022-01-28
Access archived versions of this list.
Drug or Class of Drug; Brand Name, Medicinal Ingredient(s) | Dosage Form, Strength, Route of Administration | Country of Origin and Identifying Code | Name of Importer | Batch Number | Date | Information to Support Safe Use Made Available by Importer |
---|---|---|---|---|---|---|
Continuous Renal Replacement Therapy Solution; PrismaSATE BK0/3.5, Multiple Medical Ingredients | Solution, Dialysis, Intravenous Use | Mexico, License number 2369C2009 SSA | Baxter Corporation | N/A | July 13, 2021 | Contact Baxter Corporation at: 7125 Mississauga Rd., Mississauga, ON, L5N 0C2 Telephone: 1-888-719-9955 Fax: 1-905-369-6560 |
Continuous Renal Replacement Therapy Solution; PrismaSol BGK4/2.5, Multiple Medical Ingredients | Solution, Dialysis, Intravenous Use | United States, NDC 24571-105-06 | Baxter Corporation | N/A | July 13, 2021 | Contact Baxter Corporation at: 7125 Mississauga Rd., Mississauga, ON, L5N 0C2 Telephone: 1-888-719-9955 Fax: 1-905-369-6560 |
Continuous Renal Replacement Therapy Solution; PrismaSATE BGK4/2.5, Multiple Medical Ingredients | Solution, Dialysis, Intravenous Use | United States, License number K072908 | Baxter Corporation | N/A | July 13, 2021 | Contact Baxter Corporation at: 7125 Mississauga Rd., Mississauga, ON, L5N 0C2 Telephone: 1-888-719-9955 Fax: 1-905-369-6560 |
Sarilumab; Kevzara, Sarilumab | Solution for Injection, 200 mg/1.4 mL, Subcutaneous Use | Argentina, 58.665 | Sanofi-Aventis Canada | N/A | June 3, 2021 | Sanofi Canada Head Office 2905 Place Louis-R.-Renaud, Laval, QC H7V 0A3 514-956-6200 |
Tocilizumab; Actemra, Tocilizumab | Solution, 80 mg/4 mL, Intravenous Use |
Switzerland, Global Trade Item Number (GTIN): 07640128015161 | Hoffmann-La Roche | N/A | February 22, 2021 | Contact Hoffmann-La Roche at: 7070 Mississauga Road Mississauga, ON L5N 5M8 Telephone: 1-888-762-4388 Fax: 1-905-542-5610 |
Tocilizumab; Actemra, Tocilizumab | Solution, 200 mg/10 mL, Intravenous Use |
Switzerland, Global Trade Item Number (GTIN): 00056090899314 | Hoffmann-La Roche | N/A | February 22, 2021 | Contact Hoffmann-La Roche at: 7070 Mississauga Road Mississauga, ON L5N 5M8 Telephone: 1-888-762-4388 Fax: 1-905-542-5610 |
Tocilizumab; Actemra, Tocilizumab | Solution, 400 mg/20 mL, Intravenous Use |
Switzerland, Global Trade Item Number (GTIN): 07640128015208 | Hoffmann-La Roche | N/A | February 22, 2021 | Contact Hoffmann-La Roche at: 7070 Mississauga Road Mississauga, ON L5N 5M8 Telephone: 1-888-762-4388 Fax: 1-905-542-5610 |
Propofol; Fresenius Propoven, Propofol |
Emulsion for injection or infusion, 100mL vial - 20mg/mL (2%), Intravenous use |
Austria and Sweden, Inner vial label: M080395 Outer box label: M080396 Package leaflet: M080510 |
Fresenius Kabi Canada Ltd. | N/A | April 16, 2020 | Dear Healthcare Professional Letter |
Midazolam; Midazolam Injection, USP 2 mg / 2 mL (1 mg / mL), Midazolam |
Solution for injection, 1 mg/1 mL, Intravenous and intermuscular use |
United States, ANDA 203460 |
Fresenius Kabi Canada Ltd. | N/A | April 17, 2020 | Contact Fresenius Kabi Canada at: 100-165 Galaxy Blvd., Toronto, ON M9W 0C8 Telephone: 1-877-779-7760; Fax: 1-844-605-4465 |
Ketamine; Ketamine Hydrochloride Injection USP 500mg/5mL, Ketamine Hydrochloride |
Solution - concentrate, 100mg/mL, Intramuscular or intravenous use |
United States, National Drug Code (NDC): 00409-2051-05 |
Pfizer Canada ULC | N/A | April 17, 2020 | Dear Healthcare Professional Letter |
Norepinephrine; Levophed Injection USP 4mg/4mL, Norepinephrine Bitartrate |
Solution - concentrate, 1mg/mL, Intravenous infusion following dilution |
United States, National Drug Code (NDC): 00409-3375-04 |
Pfizer Canada ULC | N/A | April 17, 2020 | Contact Pfizer Canada at: 17300 Trans-Canada Hwy., Kirkland, QC H9J 2M5 Telephone: 1-866-723-7111 Fax: 1-855-242-5652 |
Midazolam; Midazolam Injection USP 2mg/2mL, Midazolam |
Solution, 1mg/mL, Intramuscular or intravenous use |
United States, National Drug Code (NDC): 00409-2305-17 |
Pfizer Canada ULC | N/A | April 17, 2020 | Contact Pfizer Canada at: 17300 Trans-Canada Hwy., Kirkland, QC H9J 2M5 Telephone: 1-866-723-7111 Fax: 1-855-242-5652 |
Midazolam; Midazolam Injection USP 5mg/5mL, Midazolam |
Solution, 1mg/mL, Intramuscular or intravenous use |
United States, National Drug Code (NDC): 00409-2305-05 |
Pfizer Canada ULC | N/A | April 17, 2020 | Contact Pfizer Canada at: 17300 Trans-Canada Hwy., Kirkland, QC H9J 2M5 Telephone: 1-866-723-7111 Fax: 1-855-242-5652 |
Midazolam; Midazolam Injection USP 10mg/10mL, Midazolam |
Solution, 1mg/mL, Intramuscular or intravenous use |
United States, National Drug Code (NDC): 0409-2587-05 |
Pfizer Canada ULC | N/A | April 17, 2020 | Contact Pfizer Canada at: 17300 Trans-Canada Hwy., Kirkland, QC H9J 2M5 Telephone: 1-866-723-7111 Fax: 1-855-242-5652 |
Pancuronium; Pancuronium Bromide Injection USP 10mg/10mL, Pancuronium Bromide |
Solution, 1mg/mL, Intravenous use only |
United States, National Drug Code (NDC): 00409-4646-01 |
Pfizer Canada ULC | N/A | April 17, 2020 | Dear Healthcare Professional Letter |
Dexmedetomidine; Precedex injection 200mcg/2mL, Dexmedetomidine Hydrochloride |
Solution - concentrate, 100mcg/mL, Intravenous use |
United States, National Drug Code (NDC): 00409-1638-02 |
Pfizer Canada ULC | N/A | April 17, 2020 | Contact Pfizer Canada at: 17300 Trans-Canada Hwy., Kirkland, QC H9J 2M5 Telephone: 1-866-723-7111 Fax: 1-855-242-5652 |
Dexmedetomidine; Dexmedetomidina EVER Pharma, Dexmedetomidine |
Solution, 200mcg/2mL (100mcg/1mL), Intravenous use |
Spain, 719696.9 O H |
Marcan Pharmaceuticals Inc. | N/A | September 3, 2020 | Contact Marcan Pharmaceuticals Inc. at: 112 - 2 Gurdwara Road, Ottawa, Ontario K2E 1A2 Telephone: 1-613-228-2600 |
Dexmedetomidine Hydrochloride | Solution – concentrate, 100 mcg/mL, Intravenous use |
Spain 34009 550 756 7 7 (product approved in France) |
Sterinova Inc. | N/A | January 22, 2021 | Contact Sterinova Inc at: 3005 Avenue José-Maria-Rosell, Saint Hyacinthe, QC JS2 0J9 Telephone: 450-252-2520 |
Dexmedetomidine; Precedex injection 400mcg/100mL, Dexmedetomidine Hydrochloride |
Solution, 4mcg/mL, Intravenous use |
United States, National Drug Code (NDC): 00409-1660-10 |
Pfizer Canada ULC | N/A | April 17, 2020 | Contact Pfizer Canada at: 17300 Trans-Canada Hwy., Kirkland, QC H9J 2M5 Telephone: 1-866-723-7111 Fax: 1-855-242-5652 |
Succinylcholine Chloride; Quelicin Injection USP 200mg/10mL, Succinylcholine Chloride |
Solution, 20mg/mL, Intramuscular or intravenous use |
United States, National Drug Code (NDC): 00409-6629-02 |
Pfizer Canada ULC | N/A | April 17, 2020 | Dear Healthcare Professional Letter |
Rocuronium; Rocuronium Bromide injection 100mg/10mL, Rocuronium Bromide |
Solution, 10mg/mL, Intravenous use only |
United States, National Drug Code (NDC): 00409-9558-10 |
Pfizer Canada ULC | N/A | April 17, 2020 | Dear Healthcare Professional Letter |
Vecuronium; Vecuronium Bromide for Injection 10mg, Vecuronium Bromide |
Powder for solution, Intravenous use only |
United States, National Drug Code (NDC): 00409-1632-01 |
Pfizer Canada ULC | N/A | April 17, 2020 | Dear Healthcare Professional Letter |
Continuous Renal Replacement Therapy Solution; PrismaSol BGK4/0/1.2, Multiple Medical Ingredients |
Solution,Dialysis, Intravenous Use |
United States, NDC 24571-114-06 |
Baxter Corporation | N/A | July 12, 2021 | Contact Baxter Corporation at: 7125 Mississauga Rd., Mississauga, ON, L5N 0C2 Telephone: 1-888-719-9955 Fax: 1-905-369-6560 |
Continuous Renal Replacement Therapy Solution; PrismaSATE BGK4/0/1.2, Multiple Medical Ingredients |
Solution, Dialysis, Intravenous Use |
United States, License Number K072908 |
Baxter Corporation | N/A | July 12, 2021 | Contact Baxter Corporation at: 7125 Mississauga Rd., Mississauga, ON, L5N 0C2 Telephone: 1-888-719-9955 Fax: 1-905-369-6560 |
Rocuronium Bromide; Rocuronium Bromide Injection, Rocuronium Bromide |
Solution (sterile), 50mg/5mL (10mg/mL), Intravenous use |
United States, National Drug Code (NDC): 70860-651-05; 70860-651-41, ANDA: 205656 |
SteriMax Inc. | N/A | May 1, 2020 | Dear Healthcare Professional Letter |
Salbutamol; Salbutamol Aldo-Union, Salbutamol Sulfate |
Metered-Dose Aerosol, 100mcg per actuation, Inhalation |
Spain, National Health Care Reimbursement Number (NHRN): 797183.2 TLDO; M.A. No. 65.850 |
JAMP Pharma Corporation | N/A | May 7, 2020 | Dear Healthcare Professional Letter |
Azithromycin; Azithromycin for Injection USP, Azithromycin Dihydrate |
Powder for solution, 500mg/vial, Intravenous use |
Canada, DIN: 02239952 |
SteriMax Inc. | 200570110 | May 7, 2020 | Canadian Product Monograph |
Fentanyl; Fentanyl Kalceks, Fentanyl Citrate |
Liquid solution for injection, 50mcg/ml - 10ml ampoules, Intramuscular or intravenous use |
Malta, MA1207/00202 |
Innomar Strategies Inc. on behalf of JAMP Pharma Corporation | N/A | May 7, 2020 | Contact JAMP Pharma at: 1310 Nobel St., Boucherville, QC J4B 5H3 Telephone: 1-866-399-9091 x 2 |
Fentanyl; Fentanyl Citrate - Kalceks, Fentanyl Citrate |
Liquid solution for injection, 50mcg/ml - 2ml ampoules, Intramuscular or intravenous use |
Latvia, 14-0232 |
Innomar Strategies Inc. on behalf of JAMP Pharma Corporation | N/A | May 7, 2020 | Contact JAMP Pharma at: 1310 Nobel St., Boucherville, QC J4B 5H3 Telephone: 1-866-399-9091 x 2 |
Morphine; Morphine Sulfate, Morphine Sulfate Pentahydrate |
Solution, 2mg/mL, Intramuscular, intravenous, and subcutaneous use |
Australia, AUST R 308716 |
Innomar Strategies Inc. on behalf of JAMP Pharma Corporation | N/A | May 7, 2020 | Contact JAMP Pharma at: 1310 Nobel St., Boucherville, QC J4B 5H3 Telephone: 1-866-399-9091 x 2 |
Morphine; Morphine Sulfate, Morphine Sulfate Pentahydrate |
Solution, 10mg/mL, Intramuscular, intravenous, and subcutaneous use |
Australia, AUST R 308718 |
Innomar Strategies Inc. on behalf of JAMP Pharma Corporation | N/A | May 7, 2020 | Contact JAMP Pharma at: 1310 Nobel St., Boucherville, QC J4B 5H3 Telephone: 1-866-399-9091 x 2 |
Morphine; Morphine Sulfate, Morphine Sulfate Pentahydrate |
Solution, 15mg/mL, Intramuscular, intravenous, and subcutaneous use |
Australia, AUST R 308715 |
Innomar Strategies Inc. on behalf of JAMP Pharma Corporation | N/A | May 7, 2020 | Contact JAMP Pharma at: 1310 Nobel St., Boucherville, QC J4B 5H3 Telephone: 1-866-399-9091 x 2 |
Morphine; Morphine Sulfate Injection USP, Morphine Sulfate |
Solution, 5mg/mL, Intramuscular, intravenous, and subcutaneous use |
United States, National Drug Code (NDC): 76045-006-10 |
Fresenius Kabi Canada Ltd. | N/A | May 7, 2020 | Contact Fresenius Kabi Canada at: 100-165 Galaxy Blvd., Toronto, ON M9W 0C8 Telephone: 1-877-779-7760; Fax: 1-844-605-4465 |
Morphine; Morphine Sulfate Injection USP, Morphine Sulfate |
Solution, 4mg/mL Intramuscular, intravenous, and subcutaneous use |
United States, National Drug Code (NDC): 76045-005-10 |
Fresenius Kabi Canada Ltd. | N/A | May 7, 2020 | Contact Fresenius Kabi Canada at: 100-165 Galaxy Blvd., Toronto, ON M9W 0C8 Telephone: 1-877-779-7760; Fax: 1-844-605-4465 |
Morphine; Morphine Sulfate Injection USP, Morphine Sulfate |
Solution, 2mg/mL, Intramuscular, intravenous, and subcutaneous use |
United States, National Drug Code (NDC): 76045-004-10 |
Fresenius Kabi Canada Ltd. | N/A | May 7, 2020 | Contact Fresenius Kabi Canada at: 100-165 Galaxy Blvd., Toronto, ON M9W 0C8 Telephone: 1-877-779-7760; Fax: 1-844-605-4465 |
Norepinephrine; Norepinephrine Bitartrate Injection, USP 4mg/4mL (1mg/mL), Norepinephrine Bitartrate |
Injection, 1mg/mL, Intravenous use |
United States, National Drug Code (NDC): 36000-162-10 Product Code: AIN00610 |
Baxter Corporation | N/A | May 8, 2020 | Contact Baxter Corporation at: 7125 Mississauga Rd., Mississauga, ON, L5N 0C2 Telephone: 1-800-387-8399 Fax: 1-905-369-6560 |
Palivizumab; Synagis, palivizumab | Solution, 100 mg/mL, Intramuscular injection |
Poland EU/1/99/117/004 |
AstraZeneca Canada Inc. | N/A | November 19, 2021 | Contact AstraZeneca Canada at: 1004 Middlegate Road, Suite 5000 Mississauga, Ontario L4Y 1M4 Phone: 1-800-565-5877 |
Rocuronium; Rocuronium Bromide Injection, Rocuronium Bromide |
Solution for injection (50mg/5mL), 10mg/mL, Intravenous use |
United States, National Drug Code (NDC): 70860-651-05; 70860-651-41 |
Laboratoire Riva Inc. | N/A | May 8, 2020 | Dear Healthcare Professional Letter |
Hydromorphone; Hydromorphone Kalceks, Hydromorphone Hydrochloride |
Solution, 2mg/mL, Intramuscular, intravenous, or subcutaneous use |
Germany, M.A No. (Zulassungnummer): 2201455.00.00 |
Innomar Strategies Inc. on behalf of JAMP Pharma Corporation | N/A | May 11, 2020 | Contact JAMP Pharma at: 1310 Nobel St., Boucherville, QC J4B 5H3 Telephone: 1-866-399-9091 x 2 |
Hydromorphone; Hydromorphone Kalceks, Hydromorphone Hydrochloride |
Solution, 10mg/mL, Intramuscular, intravenous, or subcutaneous use |
Germany, M.A No. (Zulassungnummer): 2201456.00.00 |
Innomar Strategies Inc. on behalf of JAMP Pharma Corporation | N/A | May 11, 2020 | Contact JAMP Pharma at: 1310 Nobel St., Boucherville, QC J4B 5H3 Telephone: 1-866-399-9091 x 2 |
Hydromorphone; Hydromorphone Kalceks, Hydromorphone Hydrochloride |
Solution, 20mg/mL, Intramuscular, intravenous, or subcutaneous use |
Germany, M.A No. (Zulassungnummer): 2201457.00.00 |
Innomar Strategies Inc. on behalf of JAMP Pharma Corporation | N/A | May 11, 2020 | Contact JAMP Pharma at: 1310 Nobel St., Boucherville, QC J4B 5H3 Telephone: 1-866-399-9091 x 2 |
Hydromorphone; Hydromorphone Kalceks, Hydromorphone Hydrochloride |
Solution, 50mg/mL, Intramuscular, intravenous, or subcutaneous use |
Germany, M.A No. (Zulassungnummer): 2201458.00.00 |
Innomar Strategies Inc. on behalf of JAMP Pharma Corporation | N/A | May 11, 2020 | Contact JAMP Pharma at: 1310 Nobel St., Boucherville, QC J4B 5H3 Telephone: 1-866-399-9091 x 2 |
Timolol; Timo-Stulln, Timolol Maleate |
Ophthalmic solution, 0.5%, Ophthalmic Use |
Germany, 06879051 |
Pharma Stulln Inc. |
N/A | May 15, 2020 | Contact Pharma Stulln at: 400-6500 TransCanada hwy., Pointe-Claire, QC H9R 0A5 Telephone: 1-833-278-8556 |
Salbutamol; Salbuhaler, Salbutamol Sulfate |
Metered-Dose Aerosol, 100 mcg per actuation, Inhalation |
Philippines, DRP-3645 |
Sandoz Canada Inc. |
N/A | May 15, 2020 | Company Communication for Healthcare Professionals |
Succinylcholine; Anectine, Succinylcholine Chloride |
Solution for injection, 200mg/10mL (20mg/mL), Intravenous use |
United States, National Drug Code (NDC) - Box: 0781-9053-95; Vial: 0781-9053-70 |
Sandoz Canada Inc. | N/A | May 20, 2020 | Contact Sandoz Canada at: 110 de Lauzon, Boucherville, QC J4B 1E6 Telephone: 1-800-343-8839 |
Midazolam; Sedozolam Solution for Injection or Infusion, Midazolam |
Solution, 5mg/5mL (1mg/1mL), Intravenous or intramuscular use |
Turkey, Register Number: 2016/246 |
Innomar Strategies Inc. on behalf of JAMP Pharma Corporation | N/A | June 9, 2020 | Contact JAMP Pharma at: 1310 Nobel St., Boucherville, QC J4B 5H3 Telephone: 1-866-399-9091 x 2 |
Midazolam; Sedozolam Solution for Injection or Infusion, Midazolam |
Solution, 15mg/3mL (5mg/1mL), Intravenous or intramuscular use |
Turkey, Register Number: 2016/290 |
Innomar Strategies Inc. on behalf of JAMP Pharma Corporation | N/A | June 9, 2020 | Contact JAMP Pharma at: 1310 Nobel St., Boucherville, QC J4B 5H3 Telephone: 1-866-399-9091 x 2 |
Cisatracurium; Cisatracurium Besylate Injection, Cisatracurium Besylate |
Solution for injection, 20mg/10ml (2mg/ml), Intravenous use |
United States, National Drug Code (NDC) - Inner label: 0781-3152-70; Outer label (box of 10): 0781-3152-95 |
Sandoz Canada Incorporated | N/A | June 15, 2020 | Contact Sandoz Canada at: 110 de Lauzon, Boucherville, QC J4B 1E6 Telephone: 1-800-343-8839 |
Propylthiouracil; PTU™, Propylthiouracil |
Tablet, 50mg, Oral use |
Australia, AUST R 13313 |
Phebra Canada Inc. | N/A | June 18, 2020 | Company Communications for Healthcare Professionals |
Propofol; Disoprivan 1%, Propofol |
Solution, 500mg/50mL (1%), Intravenous use |
Switzerland, 47162 076 |
Aspen Pharmacare Canada Inc. | N/A | July 23, 2020 | Contact Aspen Pharmacare Canada Inc. at: 8 - 1155 North Service Road West, Oakville, Ontario L6M 3E3 Telephone: 1-844-330-1213 |
Rocuronium; Rocuronium Bromide injection, Rocuronium Bromide |
Solution for injection, 50mg/5mL (10mg/mL), Intravenous use |
United States, National Drug Code (NDC) - Vial: 72611-756-01; Carton: 72611-756-10 | Marcan Pharmaceuticals Inc. | N/A | July 24, 2020 | Contact Marcan Pharmaceuticals Inc. at: 112 - 2 Gurdwara Road, Ottawa, Ontario K2E 1A2 Telephone: 1-613-228-2600 |
Azithromycin; Azithromycin for Injection, USP, Azithromycin monohydrate |
Powder for solution, 500mg/vial, Intravenous use |
United States, National Drug Code (NDC): 70860-100-41 | Marcan Pharmaceuticals Inc. | N/A | July 28, 2020 | Contact Marcan Pharmaceuticals Inc. at: 112 - 2 Gurdwara Road, Ottawa, Ontario K2E 1A2 Telephone: 1-613-228-2600 |
Acyclovir; Acyclovir Sodium Injection, Acyclovir sodium |
Solution, 500mg/10mL, Intravenous use | United States, National Drug Code (NDC): 55150-154-10 | Auro Pharma Inc. | N/A | July 30, 2020 | Contact Auro Pharma Inc. at: 3700 Steeles Avenue West, Suite # 402, Woodbridge, ON L4L 8K8, Telephone: +1-905-856-8063 / +1-905-856-8263 Fax: +1-905-856-8094 |
Acyclovir; Acyclovir Sodium Injection, Acyclovir sodium |
Solution, 1000mg/20mL, Intravenous use | United States, National Drug Code (NDC): 55150-154-20 | Auro Pharma Inc. | N/A | July 30, 2020 | Contact Auro Pharma Inc. at: 3700 Steeles Avenue West, Suite # 402, Woodbridge, ON L4L 8K8 Telephone: +1-905-856-8063 / +1-905-856-8263 Fax: +1-905-856-8094 |
Propylthiouracil; Propylthiouracil 50mg Tablets; Propylthiouracil |
Tablet, 50mg, Oral use |
United Kingdom, PL 00042/0205 PA 1888-2-1 |
Accelera Pharma Canada | 61096E 61096F 61096G |
August 21, 2020 | Contact Accelera Pharma Canada at: 210B-219 Dufferin Street Toronto, ON M6K 3J1 Telephone: 1-289-208-4191 |
Midazolam; Midazolam Injection, Midazolam |
Solution for injection, 5mg/mL (50mg/10mL) Intramuscular or intravenous use |
United States, National Drug Code (NDC): 70860-601-42 |
Laboratoire Riva Inc. | N/A | September 3, 2020 | Contact Laboratoire Riva Inc. at: 660 Industrial Blvd, Blainville, QC J7C 3V4 Telephone: 450-434-7482 Fax: 450-434-2500 |
Rocuronium; Rocuronium Bromide Injection, Rocuronium Bromide |
Solution, 10mg/mL, Intravenous use |
Chile, F-24086/18 |
Formative Pharma Inc. | N/A | September 18, 2020 | Contact Formative Pharma Inc. at: 4 Robert Speck Parkway Mississauga, ON L4Z 1S1 Website: https://formativepharma.com/contact-us |
Propofol; Diprivan 10mg/mL, Propofol |
Emulsion, 10mg/mL, Intravenous use |
Italy 026114025 |
Aspen Pharmacare Inc. | N/A | September 18, 2020 | Contact Aspen Pharmacare Canada Inc. at: 8 - 1155 North Service Road West, Oakville, Ontario L6M 3E3 Telephone: 1-844-330-1213 |
Medroxyprogesterone Acetate; Depo-Provera, Medroxyprogesterone Acetate |
Suspension for Injection, 150 mg/mL, Intramuscular |
United States, National Drug Code (NDC) 0009-7376-11 | Pfizer Canada ULC | N/A | March 31, 2021 | Contact Pfizer Canada at: 17300 Trans-Canada Hwy., Kirkland, QC H9J 2M5 Telephone: 1-866-723-7111 Fax: 1-855-242-5652 |
Propofol; Propofol Injectable Emulsion, USP, Propofol |
Emulsion, 1000 mg per 100 mL (10 mg/mL), Intravenous |
USA NDC 25021-608-51 |
Omega Laboratories Limited | N/A | April 28, 2021 | Contact Omega Laboratories Limited at: 11177 Hamon Street Montreal, Quebec Canada, H3M 3E4 |
Sodium Chloride; 0.9% Sodium Chloride Injection, USP, Sodium Chloride |
Solution, 9mg/mL, Intravenous, Intramuscular or Subcutaneous use |
United States, National Drug Code (NDC): 00409-4888-10 |
Pfizer Canada ULC | N/A | January 28,2022 | Contact Pfizer Canada at: 17300 Trans-Canada Hwy., Kirkland, QC H9J 2M5 Telephone: 1-866-723-7111 Fax: 1-855-242-5652 |
Page details
- Date modified: